Monitoring of Blood L-DOPA and L-DOPA Metabolite Concentrations and Adverse Events in Patients with Advanced Parkinson's Disease Receiving L-DOPA and MAO Inhibitor Selegiline ((-)Deprenyl) Combination Therapy : A Clinical Study

被引用文献1件参考文献15件

SATOH Mitsutoshi

Department of Toxicology and Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
TSURUOKA Yumi

Department of Toxicology and Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
KUZUU Ami

Department of Toxicology and Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
DOI Hirokazu

Department of Pharmacy, Sakura Medical Center, Toho University
MASAKA Toru

Department of Pharmacy, Sakura Medical Center, Toho University
SAKAKIBARA Ryuji

Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University

この論文をさがす